XXE5XV7Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7
- Billable / Specific Code
XXE5XV7 is a billable ICD-10-PCS procedure code for Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Measurement involves determining the level of a physiological or physical function at a point in time. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Measurement and monitoring, NEC.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | X | Physiological Systems |
| 3 | Operation | E | Measurement |
| 4 | BodyPart | 5 | Circulatory |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | V | Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection |
| 7 | Qualifier | 7 | New Technology Group 7 |
In the ICD-10-PCS Alphabetic Index
These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:
Clinical Classification (CCSR)
AHRQ groups this procedure code into these clinical categories.
Similar Procedure Codes
Questions About XXE5XV7
Is XXE5XV7 a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7 on inpatient claims from October 1, 2026 through September 30, 2027.
What do the characters in XXE5XV7 mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character E is the Operation (Measurement); the 4th character 5 is the BodyPart (Circulatory); the 5th character X is the Approach (External); the 6th character V is the Device/Substance/Technology (Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection); the 7th character 7 is the Qualifier (New Technology Group 7).
